Literature DB >> 16310437

Prevalence of mechanical dyssynchrony in patients with heart failure and preserved left ventricular function (a report from the Belgian Multicenter Registry on dyssynchrony).

Johan De Sutter1, Nico R Van de Veire, Luc Muyldermans, Tine De Backer, Etienne Hoffer, Marc Vaerenberg, Bernard Paelinck, Pierre Decoodt, Laurence Gabriel, Thierry C Gillebert, Guy Van Camp.   

Abstract

The present study evaluated the prevalence of mechanical inter- and intraventricular dyssynchrony in patients with heart failure and preserved left ventricular (LV) ejection fraction (LVEF). We studied 138 patients with heart failure (age 67+/-11 years; 76% men); 60 patients had preserved LVEF (>40%). Using conventional Doppler echocardiography, an interventricular mechanical delay>or=40 ms was defined as interventricular dyssynchrony. Using pulse-wave tissue Doppler imaging, the time from the beginning of the QRS complex to onset of systolic motion was measured in 4 basal LV segments. A dispersion of >or=60 ms was defined as intraventricular dyssynchrony. The prevalence of inter- and intraventricular dyssynchrony was lower in patients with preserved LVEF than in those with reduced LVEF (17% vs 41%, p<0.01 for interventricular dyssynchrony, 18% vs 36%, p<0.01 for intraventricular dyssynchrony). However, patients with preserved LVEF and a QRS width>or=120 ms had higher values for the parameters for inter- and intraventricular dyssynchrony than patients with a QRS width<120 ms (interventricular mechanical delay 33+/-20 vs 20+/-16 ms, p<0.05; tissue Doppler imaging dispersion 42+/-26 vs 33+/-22 ms, p<0.05). In patients with a QRS width>or=120 ms, the prevalence of inter- and intraventricular dyssynchrony was comparable for patients with preserved and reduced LVEF (42% vs 55%, p=NS for interventricular dyssynchrony and 45% vs 46%, p=NS for intraventricular dyssynchrony). In conclusion, the prevalence of inter- and intraventricular dyssynchrony was low (17% and 18%, respectively) in patients with heart failure and preserved LVEF. However, in the presence of a QRS width of >or=120 ms, this prevalence increased to almost 50%, comparable to that for patients with heart failure and reduced LVEF and a QRS width of >or=120 ms.

Entities:  

Mesh:

Year:  2005        PMID: 16310437     DOI: 10.1016/j.amjcard.2005.07.062

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Heart failure with a normal ejection fraction: treatments for a complex syndrome?

Authors:  Samuel Bernard; Mathew S Maurer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

2.  Acute and chronic response to CRT in narrow QRS patients.

Authors:  Tim Donahue; Imran Niazi; Angel Leon; Michael Stucky; Keith Herrmann
Journal:  J Cardiovasc Transl Res       Date:  2011-12-30       Impact factor: 4.132

3.  Association of left ventricular diastolic function with systolic dyssynchrony: a population study.

Authors:  Tatiana Kuznetsova; Petronille Bogaert; Malgorzata Kloch-Badelek; Daisy Thijs; Lutgard Thijs; Jan A Staessen
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2012-09-21       Impact factor: 6.875

Review 4.  New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.

Authors:  Michele Senni; Walter J Paulus; Antonello Gavazzi; Alan G Fraser; Javier Díez; Scott D Solomon; Otto A Smiseth; Marco Guazzi; Carolyn S P Lam; Aldo P Maggioni; Carsten Tschöpe; Marco Metra; Scott L Hummel; Frank Edelmann; Giuseppe Ambrosio; Andrew J Stewart Coats; Gerasimos S Filippatos; Mihai Gheorghiade; Stefan D Anker; Daniel Levy; Marc A Pfeffer; Wendy Gattis Stough; Burkert M Pieske
Journal:  Eur Heart J       Date:  2014-08-07       Impact factor: 29.983

5.  Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction.

Authors:  Angela B S Santos; Elisabeth Kraigher-Krainer; Natalie Bello; Brian Claggett; Michael R Zile; Burkert Pieske; Adriaan A Voors; John J V McMurray; Milton Packer; Toni Bransford; Marty Lefkowitz; Amil M Shah; Scott D Solomon
Journal:  Eur Heart J       Date:  2013-10-27       Impact factor: 29.983

6.  Rationale and design of the Karolinska-Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction.

Authors:  Erwan Donal; Lars H Lund; Cecilia Linde; Magnus Edner; Stéphane Lafitte; Hans Persson; Fabrice Bauer; John Ohrvik; Pierre-Vladimir Ennezat; Camilla Hage; Ida Löfman; Yves Juilliere; Damien Logeart; Geneviève Derumeaux; Pascal Gueret; Jean-Claude Daubert
Journal:  Eur J Heart Fail       Date:  2009-02       Impact factor: 15.534

7.  Assesment of myocardial ischemia by combination of tissue synchronisation imaging and dobutamine stress echocardiography.

Authors:  Muhammed Hakan Tas; Enbiya Aksakal; Yekta Gurlertop; Ziya Simsek; Fuat Gundogdu; Serdar Sevimli; Eftal Murat Bakirci; Sule Karakelleoglu
Journal:  Korean Circ J       Date:  2013-06-30       Impact factor: 3.243

8.  Electrocardiographic characteristics in patients with heart failure and normal ejection fraction: A systematic review and meta-analysis.

Authors:  Theodora Nikolaidou; Nathan A Samuel; Carl Marincowitz; David J Fox; John G F Cleland; Andrew L Clark
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-10-11       Impact factor: 1.468

9.  Assessment of Left Ventricular Dyssynchrony in Heart Failure Patients Regarding Underlying Etiology and QRS Duration.

Authors:  Mahdi Montazeri; Mehrnaz Rezvanfard; Ali Kazemisaeid; Masoumeh Lotfi Tokaldany; Azam Safir Mardanloo; Farzad Darabi; Mahmood Sheikh Fathollahi; Hakimeh Sadeghian
Journal:  J Tehran Heart Cent       Date:  2011-11-30

10.  Mechanical dyssynchrony is similar in different patterns of left bundle-branch block.

Authors:  Rodrigo Bellio de Mattos Barretto; Leopoldo Soares Piegas; Jorge Eduardo Assef; José Francisco Melo Neto; Thiago Uchoa Resende; Dalmo Antonio Moreira; David Costa Lebihan; Francisco Faustino França; Romeu Sérgio Meneghelo; Amanda Guerra Moraes Rego Sousa
Journal:  Arq Bras Cardiol       Date:  2013-09-24       Impact factor: 2.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.